John Lisman runs Lisman Legal Life sciences, providing life science companies with legal advice or representation in respect to authorisation, market access, pricing and reimbursement of medicinal products, devices, blood products, tissues, and cells. He has served on the editorial boards for several journals and publications about pharmaceutical law, including MedNous and Scrip Regulatory Affairs. He has published several books about medicines legislation and regulation in both English and Dutch, and is currently the DIA Global Forum Regional Editor for Europe. John earned his Master’s Degrees in Pharmacy and Dutch Law from Utrecht University (The Netherlands), and after professional training was admitted as an attorney to the Hague Bar.